(Q43557103)

24 November 2017

title

Is HPV-DNA testing a useful tool in predicting low-grade squamous intraepithelial lesion outcome? A retrospective longitudinal study (English)

1 reference

24 November 2017

R Zappacosta

1

1 reference

24 November 2017

D Caraceni

2

1 reference

24 November 2017

L Ciccocioppo

3

1 reference

24 November 2017

M Ottaviantonio

4

1 reference

24 November 2017

F Conti

5

1 reference

24 November 2017

S Andreozzi

6

1 reference

24 November 2017

F Petrucci

7

1 reference

24 November 2017

S Rosini

8

1 reference

24 November 2017

publication date

1 January 2010

1 reference

International Journal of Immunopathology and Pharmacology

24 November 2017

published in

1 reference

24 November 2017

volume

23

1 reference

24 November 2017

issue

1

1 reference

24 November 2017

page(s)

317-326

1 reference

Strategies for successful vaccination against hepatocellular carcinoma

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300130

Description of patients with squamous cell carcinoma in the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300130

Management of women who test positive for high-risk types of human papillomavirus: the HART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300130

Human Papillomavirus testing for the management of low-grade cervical abnormalities in the UK--Influence of age and testing strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300130

HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300130

Management and triage of women with human papillomavirus infection in follow-up for low-grade cervical disease: association of HPV-DNA and RNA-based methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300130

Evaluation of adjunctive HPV testing by Hybrid Capture II®in women with minor cytological abnormalities for the diagnosis of CIN2/3 and cost comparison with colposcopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300130

Chapter 1: HPV in the etiology of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300130

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300130

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300130

Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300130

The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300130

Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300130

Natural history and epidemiology of HPV infection and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300130

An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300130

Human papillomavirus in cervical cancer screening: important role as biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300130

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300130

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300130

Biomarkers in cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300130

10.1177/039463201002300130

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference